You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

N-803

Showing 1 - 25 of 7,923
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Trial (Bevacizumab, PD-L1 t-haNK, N-803)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Sep 25, 2023

Healthy Subjects Trial in El Segundo (N-803)

Not yet recruiting
  • Healthy Subjects
  • N-803
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Sep 14, 2023

Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)

Completed
  • Acute Myelogenous Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • N-803
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 4, 2023

Hiv, HIV, AIDS Trial in Minneapolis (N-803)

Completed
  • Hiv
  • +2 more
  • N-803
  • Minneapolis, Minnesota
  • +1 more
Jan 12, 2023

Metastatic Colorectal Cancer Trial run by the National Cancer Institute (NCI) (Retifanlimab, Therapeutic CEA, Brachyury and MUC1

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023

Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

Recruiting
  • Non Muscle Invasive Bladder Cancer
  • N803 plus Bacillus Calmette-Guerin (BCG)
  • Honolulu, Hawaii
    Island Urology
Aug 7, 2023

Castration Resistant Prostate Cancer Trial run by the National Cancer Institute (NCI) (Bintrafusp alfa, N-803, BN-Brachyury)

Not yet recruiting
  • Castration Resistant Prostate Cancer
  • Bintrafusp alfa
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Metastatic Prostate Cancer, Prostate Cancer, Prostate Tumor Trial run by the NCI (M7824, N-803, MVA-BN-Brachyury)

Recruiting
  • Metastatic Prostate Cancer
  • +4 more
  • M7824
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Gastroesophageal Junction (GEJ) Cancers, Advanced HNSCC Trial run by the NCI (N-803, Pembrolizumab, PD-L1 t-haNK)

Recruiting
  • Gastroesophageal Junction (GEJ) Cancers
  • Advanced HNSCC
  • N-803
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

NSCLC, Non-Small Cell Lung Carcinoma, NSCLC Trial run by the National Cancer Institute (NCI) (biological, drug, device)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Montanide (Registered Trademark) ISA-51 VG Adjuvant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Head Neck Cancer, Head and Neck Tumors Trial run by the NCI (M7824, N803, TriAd vaccine)

Active, not recruiting
  • Head and Neck Cancer
  • Head and Neck Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Lynch Syndrome Trial in Puerto Rico, United States (procedure, drug, other, biological)

Not yet recruiting
  • Lynch Syndrome
  • Biopsy
  • +5 more
  • Phoenix, Arizona
  • +13 more
Sep 16, 2022

NonHodgkin's Lymphoma Refractory Trial in El Segundo (N803, CD19t-haNK suspension, Cyclophosphamide)

Not yet recruiting
  • NonHodgkin's Lymphoma Refractory
  • El Segundo, California
    CSSIFM
Nov 9, 2022

Human Immunodeficiency Virus Trial in New York, Philadelphia (3BNC117-LS, 10-1074-LS, N803)

Not yet recruiting
  • Human Immunodeficiency Virus
  • New York, New York
  • +2 more
Jul 12, 2022

Bladder Cancer Trial in United States (N-803 and BCG, N-803)

Recruiting
  • Bladder Cancer
  • N-803 and BCG
  • N-803
  • Anchorage, Alaska
  • +31 more
Oct 26, 2022

NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • N-803 + Pembrolizumab
  • +9 more
  • Anchorage, Alaska
  • +34 more
Apr 4, 2022

HIV Infection Trial in United States (N-803 (IL-15 Superagonist), VRC07-523LS, 10-1074)

Recruiting
  • HIV Infection
  • N-803 (IL-15 Superagonist)
  • +2 more
  • Los Angeles, California
  • +11 more
Sep 22, 2022

Non Small Cell Lung Cancer Trial in United States (N-803 + Pembrolizumab, N-803 + Carboplatin + Nab-paclitaxel + Pembrolizumab,

Active, not recruiting
  • Non Small Cell Lung Cancer
  • N-803 + Pembrolizumab
  • +5 more
  • Anchorage, Alaska
  • +30 more
Nov 3, 2022

HIV/AIDS Trial in Bangkok (N-803)

Recruiting
  • HIV/AIDS
  • N-803
  • Bangkok, Thailand
    Thai Red Cross AIDS Research Centre
Oct 4, 2021

NSCLC, Non-small Cell Carcinoma, NSCLC Trial (Ramucirumab, Atezolizumab, N-803)

Withdrawn
  • Non-small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 28, 2021

COVID-19 Trial in Lynwood (N-803, Saline)

Active, not recruiting
  • COVID-19
  • N-803
  • Saline
  • Lynwood, California
    St. Francis
Aug 23, 2021

Merkel Cell Carcinoma Trial in United States (Avelumab, N-803, haNK™)

Terminated
  • Merkel Cell Carcinoma
  • Avelumab
  • +2 more
  • San Francisco, California
  • +4 more
Jan 7, 2022

Small Bowel Cancers, Colorectal Cancers Trial run by the NCI (CV301, MSB0011359C, N-803)

Recruiting
  • Small Bowel Cancers
  • Colorectal Cancers
  • CV301
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

HIV-1-infection Trial in Pathum Wan (VRC07-523LS, PGDM1400LS, N-803)

Not yet recruiting
  • HIV-1-infection
  • VRC07-523LS
  • +7 more
  • Pathum Wan, Bangkok, Thailand
  • +1 more
Mar 8, 2023

Advanced Triple Negative Breast Cancer Trial in Newport Beach (N-803, PD-L1 t-haNK, Sacituzumab Govitecan-Hziy)

Active, not recruiting
  • Advanced Triple Negative Breast Cancer
  • N-803
  • +3 more
  • Newport Beach, California
    Hoag Memorial Hospital
Mar 29, 2022